Skip to main content
    H

    Heron Therapeuti (HRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.28
    -0.00 (-0.74%)

    Market Cap: $59.08M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Heron Therapeuti (HRTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Heron Therapeuti (HRTX) has a latest price of $0.28 on Nov 17, 2026, 82.1% below its 52-week high of $1.57. Its price fell 74.3% over the past 12 months. The month-end price fell 98.1% over the 10 years through Oct 2026, a compound annual decline of 32.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $38.85 in Jun 2018 and its lowest $0.28 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HRTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HRTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 10.4%, and over 6 months it fell 66.7%. The month-end price fell 56.4% over the 3 years through Oct 2026, a compound annual decline of 24.2%.

    PeriodChange
    1 month-21.8%
    3 months-10.4%
    6 months-66.7%
    12 months-74.3%
    12 months, with dividends-74.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-56.4%-24.2%
    5 years-97.5%-52.1%
    10 years-98.1%-32.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 43.3%, and its weakest was 2022, when it fell 72.6%.

    YearCloseChange
    2026 through Oct 2026$0.28-78.6%
    2025$1.30-15.0%
    2024$1.53-10.0%
    2023$1.70-32.0%
    2022$2.50-72.6%
    2021$9.13-56.9%
    2020$21.16-9.9%
    2019$23.50-9.4%
    2018$25.94+43.3%
    2017$18.10+38.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.2% below its 50-day average of $0.33 and 55.5% below its 200-day average of $0.63.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.28
    52-week high$1.57-82.1%
    52-week low$0.26+8.1%
    50-day average$0.33-13.2%
    200-day average$0.63-55.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.0%.

    MeasureValue
    1-year beta2.05
    Largest fall, 1 year-81.9%
    Largest fall, 3 years-93.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HRTX

    What is HRTX's 1-year price change?

    Heron Therapeuti's price fell 74.3% over the past 12 months. With dividends included, the 12-month total return was -74.3%.

    What is HRTX's 5-year price change?

    Heron Therapeuti's month-end price fell 97.5% over the 5 years through Oct 2026, a compound annual decline of 52.1%. These figures leave out dividends.

    What is HRTX's 52-week high and low?

    Heron Therapeuti's 52-week high is $1.57 and its 52-week low is $0.26. Its latest price of $0.28 on Nov 17, 2026 is 82.1% below the high.

    What is HRTX's beta?

    Heron Therapeuti's 1-year beta against the S&P 500 is 2.05, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 81.9%.

    Is the HRTX chart free?

    Yes. Advanced Charting for HRTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.